Complex pharmacology of novel allosteric free fatty acid 3 receptor ligands

Molecular Pharmacology

Volumn 86, Issue 2, 2014, Pages 200-210

  Hudson, Brian D ^a   Christiansen, Elisabeth ^b   Murdoch, Hannah ^a   Jenkins, Laura ^a   Hansen, Anders Højgaard ^b   Madsen, Ole ^b   Ulven, Trond ^b   Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 (FURAN 2 YL) 2 METHYL 5 OXO N (2 TOLYL) 1,4,5,6,7, 8 HEXAHYDROQUINOLINE 3 CARBOXAMIDE; AGENTS AFFECTING LIPID METABOLISM; AMIDE; FREE FATTY ACID 3 RECEPTOR; FREE FATTY ACID 3 RECEPTOR AGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; UNCLASSIFIED DRUG; FFAR3 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; LIGAND;

ALLOSTERISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CONCENTRATION RESPONSE; DRUG ANTAGONISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; CELL LINE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM;

ALLOSTERIC REGULATION; CELL LINE; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84905964077     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.093294     Document Type: Article

References (39)

1. Baillie GL, Horswill JG, Anavi-Goffer S, Reggio PH, Bolognini D, Abood ME, McAllister S, Strange PG, Stephens GJ, and Pertwee RG et al. (2013) CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity. Mol Pharmacol 83:322-338.
2. Ballesteros JA, and Weinstein H (1995) Integrated methods for modeling G-protein coupled receptors. Methods Neurosci 25:366-428.
3. Bellahcene M, O'Dowd JF, Wargent ET, Zaibi MS, Hislop DC, Ngala RA, Smith DM, Cawthorne MA, Stocker CJ, and Arch JR (2013) Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br J Nutr 109:1755-1764.
4. Bergman EN (1990) Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70:567-590.
5. Bjursell M, Admyre T, Göransson M, Marley AE, Smith DM, Oscarsson J, and Bohlooly-Y M (2011) Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab 300:E211-E220.
6. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, and Fraser NJ et al. (2003) The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:11312-11319. (Pubitemid 36792688)
7. Cani PD, Everard A, and Duparc T (2013) Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 13:935-940.
8. Dranse HJ, Kelly ME, and Hudson BD (2013) Drugs or diet?-Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs. Br J Pharmacol 170:696-711.
9. Engelstoft MS, Park WM, Sakata I, Kristensen LV, Husted AS, Osborne-Lawrence S, Piper PK, Walker AK, Pedersen MH, and Nøhr MK et al. (2013) Seven trans-membrane G protein-coupled receptor repertoire of gastric ghrelin cells. Mol Metab 2:376-392.
10. Hara T, Kimura I, Inoue D, Ichimura A, and Hirasawa A (2013) Free fatty acid receptors and their role in regulation of energy metabolism. Rev Physiol Biochem Pharmacol 164:77-116.
11. Hudson BD, Smith NJ, and Milligan G (2011) Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors. Adv Pharmacol 62:175-218.
12. Hudson BD, Christiansen E, Tikhonova IG, Grundmann M, Kostenis E, Adams DR, Ulven T, and Milligan G (2012a) Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J 26:4951-4965.
13. Hudson BD, Tikhonova IG, Pandey SK, Ulven T, and Milligan G (2012b) Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3. J Biol Chem 287:41195-41209.
14. Hudson BD, Due-Hansen ME, Christiansen E, Hansen AM, Mackenzie AE, Murdoch H, Pandey SK, Ward RJ, Marquez R, and Tikhonova IG et al. (2013a) Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor. J Biol Chem 288:17296-17312.
15. Hudson BD, Ulven T, and Milligan G (2013b) The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs. Curr Top Med Chem 13:14-25.
16. Keov P, Sexton PM, and Christopoulos A (2011) Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. Neuropharmacology 60:24-35.
17. Kim MH, Kang SG, Park JH, Yanagisawa M, and Kim CH (2013) Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145:396-406.
18. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, and Tani T et al. (2013) The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4:1829.
19. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, and Van Damme J et al. (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278:25481-25489. (Pubitemid 36835299)
20. Lee T, Schwandner R, Swaminath G, Weiszmann J, Cardozo M, Greenberg J, Jaeckel P, Ge H, Wang Y, and Jiao X et al. (2008) Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol 74:1599-1609.
21. Leonard JN, Chu ZL, Bruce MA, and Boatman PD (2006) GPR41 and modulators thereof for the treatment of insulin-related disorders. PCT Int Appl WO 2006052566.
22. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, and Artis D et al. (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282-1286.
23. Milligan G, Ulven T, Murdoch H, and Hudson BD (2014) G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets. Br J Nutr 111 (Suppl 1):S3-S7.
24. Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, Sichlau RM, Grunddal KV, Seier Poulsen S, and Han S et al. (2013) GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154:3552-3564.
25. Price MR, Baillie GL, Thomas A, Stevenson LA, Easson M, Goodwin R, McLean A, McIntosh L, Goodwin G, and Walker G et al. (2005) Allosteric modulation of the cannabinoid CB1 receptor. Mol Pharmacol 68:1484-1495. (Pubitemid 41540004)
26. Schmidt J, Smith NJ, Christiansen E, Tikhonova IG, Grundmann M, Hudson BD, Ward RJ, Drewke C, Milligan G, and Kostenis E et al. (2011) Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J Biol Chem 286:10628-10640.
27. Sina C, Gavrilova O, Förster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, and Rehmann A et al. (2009) G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 183:7514-7522.
28. Smith NJ, Ward RJ, Stoddart LA, Hudson BD, Kostenis E, Ulven T, Morris JC, Tränkle C, Tikhonova IG, and Adams DR et al. (2011) Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator. Mol Pharmacol 80:163-173.
29. Stoddart LA, Smith NJ, Jenkins L, Brown AJ, and Milligan G (2008a) Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J Biol Chem 283:32913-32924.
30. Stoddart LA, Smith NJ, and Milligan G (2008b) International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol Rev 60:405-417.
31. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, and Macia L (2014) The role of short-chain fatty acids in health and disease. Adv Immunol 121:91-119.
32. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, and Gribble FM (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61:364-371.
33. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, and Harris NL et al. (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20:159-166.
34. Ulven T (2012) Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets. Front Endocrinol 3:111.
35. Vinolo MA, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly-Y M, Stephens L, Hawkins PT, and Curi R (2011) SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One 6:e21205.
36. Wang Y, Jiao X, Kayser F, Liu J, Wang Z, Wanska M, Greenberg J, Weiszmann J, Ge H, and Tian H et al. (2010) The first synthetic agonists of FFA2: discovery and SAR of phenylacetamides as allosteric modulators. Bioorg Med Chem Lett 20:493-498.
37. Wood MR, Hopkins CR, Brogan JT, Conn PJ, and Lindsley CW (2011) "Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology. Biochemistry 50:2403-2410.
38. Yonezawa T, Kurata R, Yoshida K, Murayama MA, Cui X, and Hasegawa A (2013) Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics. Curr Med Chem 20:3855-3871.
39. Zaibi MS, Stocker CJ, O'Dowd J, Davies A, Bellahcene M, Cawthorne MA, Brown AJ, Smith DM, and Arch JR (2010) Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett 584:2381-2386.